| Title : Viral target- and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivir - Yan_2023_Fundam.Clin.Pharmacol__ |
| Author(s) : Yan D , Yan B |
| Ref : Fundamental & Clinical Toxicology , : , 2023 |
| Abstract : Yan_2023_Fundam.Clin.Pharmacol__ |
| ESTHER : Yan_2023_Fundam.Clin.Pharmacol__ |
| PubMedSearch : Yan_2023_Fundam.Clin.Pharmacol__ |
| PubMedID: 36931725 |
Yan D, Yan B (2023)
Viral target- and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivir
Fundamental & Clinical Toxicology
:
Yan D, Yan B (2023)
Fundamental & Clinical Toxicology
: